ATE91236T1 - Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung. - Google Patents
Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.Info
- Publication number
- ATE91236T1 ATE91236T1 AT87114085T AT87114085T ATE91236T1 AT E91236 T1 ATE91236 T1 AT E91236T1 AT 87114085 T AT87114085 T AT 87114085T AT 87114085 T AT87114085 T AT 87114085T AT E91236 T1 ATE91236 T1 AT E91236T1
- Authority
- AT
- Austria
- Prior art keywords
- neoplasma
- manufacture
- treatment
- therapeutic agent
- follicle maturation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002710 gonadal effect Effects 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000035800 maturation Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 102000034356 gene-regulatory proteins Human genes 0.000 abstract 1
- 108091006104 gene-regulatory proteins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
- Y10S530/853—Ovary; eggs; embryos
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/915,074 US4849402A (en) | 1986-10-03 | 1986-10-03 | Therapeutic treatment of abnormal cell growth with follicle regulatory protein |
| EP87114085A EP0267402B1 (de) | 1986-10-03 | 1987-09-26 | Verwendung von Follikelreifungshormon zur Herstellung eines therapeutischen Mittels zur Behandlung von Neoplasmen von gonadalem Ursprung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE91236T1 true ATE91236T1 (de) | 1993-07-15 |
Family
ID=25435172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87114085T ATE91236T1 (de) | 1986-10-03 | 1987-09-26 | Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4849402A (de) |
| EP (1) | EP0267402B1 (de) |
| JP (1) | JPH01168622A (de) |
| AT (1) | ATE91236T1 (de) |
| AU (1) | AU600034B2 (de) |
| CA (1) | CA1295940C (de) |
| DE (1) | DE3786442T2 (de) |
| ES (1) | ES2056804T3 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734398A (en) * | 1983-03-15 | 1988-03-29 | University Of Southern California | Follicular regulating protein |
| US4764502A (en) * | 1983-03-15 | 1988-08-16 | University Of Southern California | Intragonadal regulatory protein |
| US4692332A (en) * | 1985-01-18 | 1987-09-08 | Mcmichael John | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
-
1986
- 1986-10-03 US US06/915,074 patent/US4849402A/en not_active Expired - Fee Related
-
1987
- 1987-09-26 DE DE87114085T patent/DE3786442T2/de not_active Expired - Fee Related
- 1987-09-26 ES ES87114085T patent/ES2056804T3/es not_active Expired - Lifetime
- 1987-09-26 EP EP87114085A patent/EP0267402B1/de not_active Expired - Lifetime
- 1987-09-26 AT AT87114085T patent/ATE91236T1/de not_active IP Right Cessation
- 1987-09-28 CA CA000548047A patent/CA1295940C/en not_active Expired - Lifetime
- 1987-10-02 JP JP62250561A patent/JPH01168622A/ja active Pending
- 1987-10-02 AU AU79314/87A patent/AU600034B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0267402A2 (de) | 1988-05-18 |
| AU600034B2 (en) | 1990-08-02 |
| CA1295940C (en) | 1992-02-18 |
| EP0267402A3 (en) | 1990-05-23 |
| JPH01168622A (ja) | 1989-07-04 |
| US4849402A (en) | 1989-07-18 |
| AU7931487A (en) | 1988-04-14 |
| ES2056804T3 (es) | 1994-10-16 |
| DE3786442T2 (de) | 1993-10-21 |
| EP0267402B1 (de) | 1993-07-07 |
| DE3786442D1 (de) | 1993-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
| DE68919358D1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE69012591D1 (de) | Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen. | |
| DE3752045D1 (de) | Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten | |
| DE3382458D1 (de) | Haarwuchsmittel. | |
| ATE270553T1 (de) | Anwendung von 1,2,4-benzotriazinoxiden zur herstellung eines arzneimittels zur behandlung von tumoren | |
| DE69201128D1 (de) | Behandlung von neoplastischen krankenheiten mit interleukin-10. | |
| ATE66374T1 (de) | Zubereitungen und verfahren zur behandlung von blutungsstoerungen. | |
| DE3782498D1 (de) | Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten. | |
| ATE145136T1 (de) | Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE148628T1 (de) | 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten | |
| DE69305267D1 (de) | Zusammensetzung zur Behandlung von Mastitis und Metritis | |
| ATE125709T1 (de) | Verwendung von ifn-gamma zur herstellung einer pharmazeutischen zusammensetzung für die behandlung von atl. | |
| ATE95694T1 (de) | Verwendung von bezafibrat zur behandlung von diabetes. | |
| DE69313261D1 (de) | Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS | |
| DE69301750D1 (de) | Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose | |
| DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| DE3686097D1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
| ATE91236T1 (de) | Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung. | |
| DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| DE59504374D1 (de) | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen | |
| ATE136776T1 (de) | Verwendung von heptastigmin zur behandlung der zerebralen ictus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |